Global Cancer Diagnostics Market Projections, SWOT Analysis, Risk Analysis, Trends and Forecast by 2023

According to Stratistics MRC, the Global Cancer Diagnostics market is expected to grow from $8.54 billion in 2016 to reach $22.41 billion by 2023 with a CAGR of 14.8 %. Increasing incidence of cancer diseases, growing awareness about health care, and recent technological advancements in diagnostic devices are some of the factors propelling the market growth. In addition, favorable government reimbursement policies, increasing investments in research and development activities are some other factors boosting the market growth during the forecast period. On the other hand, high costs of diagnostic devices, strict regulations for new product approvals are the factors limiting the market growth.

Browse The Report: http://www.orbisresearch.com/reports/index/cancer-diagnostics-global-market-outlook-2017-2023

Globally, cancer is the most emerging disease in recent times. Cervical, breast, liver, blood, kidney, colorectal, pancreatic, ovarian, melanoma, and lung cancers are types of cancers persisting in humans. Diagnosing at early stage can cure the disease and limit the disease severity. Research institutes have the high adoption rate of cancer diagnostic devices due to heavy funding from government and private institutions.

North America is estimated to be the dominant one among all, due to developed healthcare infrastructure, government initiatives towards public health care that are expected to drive this dominance. Asia Pacific region is predicted to grow at higher CAGR during the forecast period. The growth is attributed to rise in medical tourism market, increase in prevalence of cancer disease in countries such as Japan, China, and India are favoring the Asia Pacific market growth.

Some of the key players in global Cancer Diagnostics market include Abbott Diagnostics, Agilent Technologies, Inc., Becton, Dickinson and Company, bioMérieux, C.R. Bard, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare (A Subsidiary of General Electric Company), Hologic,Inc., Illumina, Inc., Koninklijke Philips N.V., Qiagen, Roche Diagnostics, Siemens Healthcare GmbH, and Thermo Fisher Scientific, Inc.

Request a Sample of The Report: http://www.orbisresearch.com/contacts/request-sample/454386

Technologies Covered:
Instrument-Based
Platform-Based Diagnostics
Tumor Biomarkers Tests

Applications Covered:
Cervical Cancer
Breast Cancer
Liver Cancer
Blood Cancer
Kidney Cancer
Colorectal Cancer
Pancreatic Cancer
Ovarian Cancer
Melanoma
Lung Cancer
Other Cancers

End Users Covered:
Cancer Research Institutes
Diagnostic Laboratories
Hospital Associated Labs
Other End Users

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
UK
Italy
France
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
South America
Argentina
Brazil
Chile
Rest of South America
Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

List Of Tables:
Table 1 Global Cancer Diagnostics Market Outlook, By Region
Table 2 Global Cancer Diagnostics Market Outlook, By Technology
Table 3 Global Cancer Diagnostics Market Outlook, By Instrument-Based
Table 4 Global Cancer Diagnostics Market Outlook, By Biopsies
Table 5 Global Cancer Diagnostics Market Outlook, By Liquid Biopsy
Table 6 Global Cancer Diagnostics Market Outlook, By Diagnostic Imaging
Table 7 Global Cancer Diagnostics Market Outlook, By Platform-Based Diagnostics
Table 8 Global Cancer Diagnostics Market Outlook, By Immunohistochemistry (IHC)
Table 9 Global Cancer Diagnostics Market Outlook, By Flow Cytometry
Table 10 Global Cancer Diagnostics Market Outlook, By In Situ Hybridization (ISH)
Table 11 Global Cancer Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR)
Table 12 Global Cancer Diagnostics Market Outlook, By Next-Generation Sequencing (NGS)
Table 13 Global Cancer Diagnostics Market Outlook, By Microarrays
Table 14 Global Cancer Diagnostics Market Outlook, By Other Technologies
Table 15 Global Cancer Diagnostics Market Outlook, By Tumor Biomarkers Tests
Table 16 Global Cancer Diagnostics Market Outlook, By AFP Tests
Table 17 Global Cancer Diagnostics Market Outlook, By CA-19 Tests
Table 18 Global Cancer Diagnostics Market Outlook, By BRCA Tests
Table 19 Global Cancer Diagnostics Market Outlook, By ALK Tests
Table 20 Global Cancer Diagnostics Market Outlook, By CEA Tests

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s